1 June 2020
BDA advises FountainVest on sale of Kehua Bio-Engineering to Gree Real Estate

divested significant stake in

Kehua Bio-Engineering to Gree Real Estate
2020
Recent transactions

invested in

a portfolio company of

2025

has divested strategic stake to


2025

divested majority stake in

to

2024

acquired majority stake in


2024

has been acquired by


2023

received investment from


2023

a subsidiary of

has acquired

2022

a portfolio company of

has been acquired by

2022

agreed to divest East Syracuse, New York facility to


2022

has sold minority stake to


2022

a portfolio company of

has been acquired by

2022

investment from


2021

has been acquired by


2021

a portfolio company of

has been acquired majority stake by

2021

a portfolio company of

has been acquired by

2021

divested majority stake to


DCP Capital
2021

agreed to divest Couvet, Switzerland facility to WuXi AppTec


2021

raised Series B round from


2021

backed by

has been acquired by

2020

divested Escientia Life Sciences to Deccan Fine Chemicals


2020


















